Hemolock AR Gel is a topical hemostatic formulation containing Centbucridine (0.5% w/w) and Feracrylum (3% w/w), designed to effectively control bleeding in various clinical and surgical settings. Centbucridine, a potent local anesthetic with vasoconstrictive properties, aids in rapid hemostasis by reducing blood flow at the site of application, while simultaneously providing analgesic effects to minimize patient discomfort. Feracrylum, a polymeric iron compound, promotes coagulation through the formation of a stable, insoluble ferric ion-protein complex that facilitates clot formation and wound sealing. The synergistic action of these active ingredients ensures prompt cessation of bleeding, making Hemolock AR Gel suitable for use in minor surgical procedures, dental surgeries, traumatic wounds, and other superficial bleeding conditions. Its gel formulation allows for easy application and adherence to the wound site, enhancing localized action without systemic absorption. Hemolock AR Gel is intended for external use only and should be applied directly to the bleeding site following standard aseptic techniques. It is contraindicated in patients with known hypersensitivity to any component. Proper use of Hemolock AR Gel can significantly reduce bleeding time, promote wound healing, and improve patient outcomes in clinical practice.